NCT00586261View on ClinicalTrials.gov

Does Thiazolidinedione Therapy Improve Endothelial Function and Preserve Renal Function

NATerminatedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

January 31, 2009

Study Completion Date

July 31, 2009

Conditions
Chronic Kidney Disease
Interventions
DRUG

Pioglitazone

Pioglitazone 30 mg daily for 6 months

DRUG

Placebo

Placebo 30 mg daily for 6 months

DRUG

Nitroglycerin

0.4 mg sublingual nitroglycerin tablet was given to all patients without a contraindication to check the brachial reactivity.

Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER